Don’t Light the Fuse of Restless Legs Syndrome with Dopamine Agonists
Twenty percent of restless legs syndrome patients are already on higher-than-recommended doses of dopamine agonists, says John Winkelman, MD, PhD.
Category: Restless Legs Syndrome
Restless Legs Syndrome
Latest
Restless Legs Syndrome
Latest
New Susceptibility Genes IDed for Restless Leg Syndrome
In a transcriptome-wide study, researchers pinpoint PPP3R1 and other novel genetic risk factors of interest in RLS.
Restless Legs Syndrome
LatestRestless Legs Syndrome Research Reaches Its Stride
The discovery of how restless legs syndrome patients lack iron availability in a part of their brains is due to the work of Christopher Earley, MBBCh, PhD, and his research collaborators, whose initial work launched a decades-long investigation into the pathophysiology of RLS.
Autism & Sleep: Scientists Are One Step Closer to Solving the Puzzle
Sleep issues in children with autism are often written off as behavioral problems, but emerging science is unraveling a more complex picture.
Read More
Webinar: Restless Legs Syndrome and Brain Donation
The RLS Foundation is hosting a webinar on the “Brain Donor Project” with Tish Hevel, CEO of The Brain Donor Project, who will discuss what brain donation is and how patients can donate their tissue to further RLS research.
Read More
The Effect of the COVID-19 Vaccine on Restless Legs
A patient with restless legs syndrome writes into The Seattle Times’ Wellness section to ask about how the COVID-19 Moderna vaccine could impact her symptoms.
Read More
Survey: Only 29% of People with RLS Say Sleep Disorder Is Controlled on Current Treatment Plan
Four in 10 don’t feel treatment options are clearly explained and 45% aren’t in complete agreement with their HCP on their RLS severity.
Read More
Factors Affecting New-Onset of Restless Legs Syndrome in Pregnancy
Pregnant women often develop restless legs syndrome (RLS), however the incidence of RLS in this population was associated with ethnicity, age, and nutritional factors according to study results published in Neurology.
Read More
Relaxis for RLS Is Discontinued
Relaxis, a vibratory counterstimulation device for RLS patients that was FDA cleared in 2014, is no longer filling new prescriptions.
Read More
A Neurologist Remembers His Friend and Research Collaborator Richard P. Allen, PhD
Restless legs syndrome pioneer Richard Allen died on Dec 9, 2020, with his family by his side.
Read MoreObit: Richard P. Allen, PhD
Dignity Memorial: Restless legs syndrome pioneer Riichard Putnam Allen, 82, of Arnold, Maryland, passed away on December 9, 2020 at home, with his family by his side.
Read MoreWearable RLS Therapy Developer Completes $17M Million Series B Financing
Noctrix Health is developing a neuromodulation-based approach to treat RLS and has obtained a Breakthrough Device Designation from the FDA.
Read MoreRace & Ethnicity May Not Play Role in RLS During Pregnancy
Penn State investigators found differences between different racial and ethnic groups and the prevalence of restless legs syndrome during pregnancy, but they do not believe that race was the cause of the differences.
Read More
Reducing RLS Augmentation: Scientist Identifies a New Pathway to Maintain Restless Legs Syndrome Treatment Efficacy
A patent proposes a new treatment method that targets the increased D1 receptor levels in RLS patients experiencing augmentation.
Read MoreCannabis for Restless Leg Syndrome
Psychology Today examines how the blend of chemicals in the cannabis plant acts within the brains of people with restless leg syndrome.
Read More
Are Dopamine Agonists Doing More Harm Than Good for Restless Legs Syndrome Patients?
A new study finds about 20% of restless legs syndrome patients are prescribed doses above the recommended maximum.
Read More
Why I Evaluate My Neuropathy Patients for Restless Legs Syndrome
New research finds that small fiber neuropathy is linked with RLS and has a significant impact on quality of life.
Read More
Wearable Restless Legs Syndrome Therapy Granted FDA Breakthrough Device Designation
Noctrix Health aims to treat RLS symptoms with its wearable neuromodulation platform that targets specific peripheral nerve fibers in a manner that is comfortable to wear to sleep.
Read More